Cyclophosphamide (CP) is an alkylating cytostatic agent used in the treatment of various cancers and autoimmune diseases. Its most significant adverse effect is hemorrhagic cystitis, caused by the toxic metabolite acrolein. Despite extensive research on acute non-bacterial cystitis, the role of T lymphocytes in the immune response of the urinary bladder following CP-induced injury is not yet fully understood. In this thesis, we investigated the effect of intraperitoneal (i.p.) injection of CP on the presence and distribution of CD4+ and CD8+ lymphocytes in the urinary bladder wall of mice. We employed a mouse model of acute non-bacterial cystitis, in which mice received a single i.p. injection of 150 mg CP/kg body weight (CP150 group) or 300 mg CP/kg body weight (CP300 group). The control group received an i.p. injection of physiological saline. Histological changes were evaluated on hematoxylin and eosin-stained paraffin sections, whereas the presence and localization of T lymphocytes were determined using immunofluorescence staining. T-lymphocyte density was quantified and evaluated using statistical analysis. Following CP administration, damage to the urothelium and lamina propria was observed, including urothelial desquamation, hyperplasia, edema, inflammatory infiltration, and hemorrhage. Morphological changes were more pronounced in the CP300 group. Immunofluorescence analysis demonstrated that across all groups, CD4+ and CD8+ lymphocytes were localized predominantly within the lamina propria. The lower CP dose was characterized by an increase in CD4+ lymphocytes, whereas the results regarding CD8+ lymphocytes were inconclusive. In contrast, the higher dose was associated with a reduction in both T lymphocyte populations. Statistical analysis identified significant differences for both CD4+ and CD8+ lymphocytes between groups treated with different CP doses, confirming a dose-dependent effect of CP on the local immune response. Further large-scale studies are needed to improve our understanding of the role of CD4+ and CD8+ lymphocytes in cyclophosphamide-induced cystitis.
|